← Back to patent-cliff list
CAS 106192-66-9
(2R,3R,4S,5R)-2-azido-6-methylenetetrahydro-2H-pyran-3,4,5-triyl triacetate
Codes: MIGA-022
Application context (from source-drug indications)
Fabry diseaseMigalastat Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Migalastat Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2R,3R,4S,5R)-2-azido-6-methylenetetrahydro-2H-pyran-3,4,5-triyl triacetate→(3R,4R,5R,6R)-2-(acetoxymethyl)-6-azido-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate→(3R,4R,5R,6R)-6-azido-2-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol→(2R,3R,4S,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.